SuchitaPakkalaMD

Oncology • Atlanta, GA

Instructor, Hematology and Medical Oncology, Emory University School of Medicine

Join to view full profile

Dr. Pakkala is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pakkala's full profile

Already have an account?

Office
1365C Clifton Rd NE
Atlanta, GA 30322
Phone+1 404-686-1000

Fax+1 404-778-5520

Education & Training

Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2007 - 2010
Emory University School of MedicineResidency, Internal Medicine, 2004 - 2007
University of Tennessee Health Science Center College of MedicineClass of 2004

Certifications & Licensure

GA State Medical License 2007 - 2025
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC
No longer available
A Study to Evaluate the Efficacy of Brigatinib (AP26113) in Participants With Anaplastic Lymphoma Kinase (ALK)-Positive, Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib Start of enrollment: 2014 Jun 04
Completed
Phase 2

Publications & Presentations

PubMed

4 citations
A Phase 2 Study of Docetaxel, Ramucirumab, and Pembrolizumab for Patients With Metastatic or Recurrent Non-Small-Cell Lung Cancer (NSCLC) who Progressed on Platinum-Do...
Badi El Osta, Jennifer Carlisle, Conor Steuer, Suchita Pakkala, Ticiana Leal
Clinical Lung Cancer. 2022-11-01
3 citations
A Safety Analysis of Programmed Death 1 Pathway Inhibitors in Patients With Solid Tumor Malignancies and Preexisting Autoimmune Disease.
Jordyn Paige Higgins, Anh Viet Trinh, Marley L Watson, Tyler Beardslee, Subir Goyal
Journal of Clinical Rheumatology. 2022-10-01
40 citations
Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study
Suchita Pakkala, Kristin Higgins, Zhengjia Chen, Gabriel Sica, Conor E. Steuer
Journal for Immunotherapy of Cancer. 2020-12-01

Journal Articles

Concurrent Chemoradiotherapy with Weekly Versus Triweekly Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Comparative Analysis
Rathi Pillai, Fadlo R Khuri, Nabil F Saba, Conor Steuer, Suchita Pakkala, Kristin Higgins, Jonathan J Beitler, Suresh S Ramalingam, Brandon Twardy, Kelly Schrapp, Taof..., Head & Neck

Professional Memberships

American Society of Clinical Oncology - ASCO
Member